Medical Technology News 22 October 2025

Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

As of the close on 5 December 2025, Medtronic plc (NYSE: MDT) stock trades around $101.36–$101.39 per share, giving the medical device giant a market capitalization of roughly $130 billion, a P/E ratio near 27.4, and a dividend yield of

6 December 2025

Intuitive Surgical (ISRG) Stock in December 2025: Earnings Beat, Tariff Risks and New Robotic Rivals

Published: December 6, 2025 Intuitive Surgical, Inc. (NASDAQ: ISRG), the pioneer of robotic-assisted surgery and maker of the da Vinci and Ion systems, remains one of the most closely watched healthcare stocks as 2025 draws to a close. The company

6 December 2025

Earnings Reports · Investment Strategies · Market Competition · Medical Technology · NASDAQ:ISRG · Stock Analysis

Picard Medical (PMI) Stock Soars 82% After Artificial Heart Breakthrough: Is This Rally Sustainable?

Picard Medical, Inc. (NYSE American: PMI) just staged one of the most dramatic moves on Wall Street, with its stock surging more than 80% on December 4, 2025, after the company released new data on its next‑generation artificial heart. Investors

5 December 2025

Biotechnology · Healthcare Innovation · Investment Analysis · Medical Technology · Stock Market

Medtronic (MDT) Stock Near 52‑Week High as Truist Hikes Target and Norges Bank Buys Big

Medtronic plc (NYSE: MDT) is back in the spotlight on 29 November 2025, with its stock trading close to record levels after a strong earnings beat, a fresh wave of analyst updates and sizeable moves from some of the world’s

30 November 2025

Company Analysis · Financial News · Investments · Medical Technology · Stock Market

Abbott Laboratories (ABT) Stock Today, November 26, 2025: Insider Sale, $21B Exact Sciences Deal and Libre 3 Sensor Correction in Focus

Abbott Laboratories (NYSE: ABT) enters Wednesday, November 26, 2025 with its share price hovering around $128 after a modest gain in Tuesday’s session. Investors are weighing three main storylines: a fresh insider stock sale, the $21 billion takeover of Exact

26 November 2025

Healthcare Industry · Insider Trading · Medical Technology · Mergers & Acquisitions · NYSE:ABT · Stock Market

Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (NYSE: ABT) shook the healthcare and medtech markets today, November 20, 2025, by announcing a definitive agreement to acquire cancer diagnostics specialist Exact Sciences Corporation (NASDAQ: EXAS) in an all‑cash transaction valuing the target at about $21 billion

20 November 2025

Cancer Research · Healthcare · Medical Technology · Mergers & Acquisitions · NASDAQ:EXAS · NYSE:ABT · Stock Market News

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott has agreed to acquire cancer diagnostics specialist Exact Sciences in a cash deal valued at about $21 billion in equity, or roughly $23 billion including debt, in one of the biggest healthcare transactions of 2025 and Abbott’s largest deal

20 November 2025

Business News · Cancer Research · Healthcare · Medical Technology · Mergers & Acquisitions · NASDAQ:EXAS · NYSE:ABT

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025

Abbott Laboratories is in advanced talks to acquire cancer diagnostics specialist Exact Sciences, in what could be the healthcare giant’s largest deal in nearly a decade and a major shake-up for the global cancer testing market. Bloomberg+1 Abbott in Talks

19 November 2025

Cancer Research · Healthcare · Medical Technology · Mergers & Acquisitions · Stock Market

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific Corporation (NYSE: BSX) shares traded lower on Wednesday, November 19, 2025, even as a wave of fresh research, strategic partnership news and institutional ownership updates painted a largely constructive long‑term picture for the medtech giant. BSX stock price

19 November 2025

Company News · Healthcare Investments · Market Trends · Medical Technology · NYSE:BSX · Stock Analysis

ClearPoint Neuro (CLPT) Stock Skyrockets on Brain Therapy Breakthroughs – 2025 Deep Dive

Stock Performance & Trading Trends (2025) ClearPoint Neuro’s stock has delivered dramatic gains in 2025, transforming from a little-known small-cap into a high-flyer. The share price rallied over 300% from 2024 lows, driven by positive news in both the company’s

3 November 2025

Health Innovation · Investment Insights · Medical Technology · Neuroscience · Stock Market

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific’s Q3 report blew past expectations. Marlborough, MA-based Boston Scientific (NYSE:BSX) posted reported net income of $755 M ($0.51/share GAAP) and adjusted EPS of $0.75 timesunion.com chartmill.com, topping the $0.71–$0.72 analysts’ forecast. CEO Mike Mahoney called it “another exceptional quarter

22 October 2025

Earnings Reports · Investing · Market News · Medical Technology · Stocks

Intuitive Surgical Stock Rockets 17% After Blowout Q3 Earnings – Is $600 Next?

Intuitive Surgical’s da Vinci surgical robot in an operating room setting. Intuitive’s stock jumped on Oct. 21 after the company reported blowout Q3 results and raised full-year guidance reuters.com ts2.tech. The quarter’s 23% revenue growth was driven by a surge

22 October 2025

Earnings Reports · Financial Analysis · Investing · Medical Technology · NASDAQ:ISRG · Stock Market

Medical Technology News 22 October 2025 - 6 December 2025